Why the study?
Does EDTA chelation therapy improve clinical outcomes in patients with atherosclerotic cardiovascular disease?
Does EDTA chelation therapy improve clinical outcomes in patients with atherosclerotic cardiovascular disease?
Answers are grounded in this paper and cite their sources.
EDTA chelation therapy is an emerging alternative treatment for atherosclerosis, but current evidence remains insufficient to determine its clinical effectiveness.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mali et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: